Motif ID: Yy1_Yy2
Z-value: 3.088
Transcription factors associated with Yy1_Yy2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Yy1 | ENSMUSG00000021264.11 | Yy1 |
| Yy2 | ENSMUSG00000091736.2 | Yy2 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Yy2 | mm10_v2_chrX_-_157598642_157598655 | -0.46 | 3.9e-04 | Click! |
| Yy1 | mm10_v2_chr12_+_108792946_108792988 | 0.16 | 2.5e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.5 | 30.0 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
| 5.5 | 5.5 | GO:0045608 | inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 5.5 | 16.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 4.9 | 34.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 4.4 | 13.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 3.9 | 11.6 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 3.6 | 3.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 3.5 | 108.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 3.3 | 9.9 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
| 3.2 | 9.6 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 3.1 | 9.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 3.1 | 15.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 3.1 | 3.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 3.1 | 9.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 3.0 | 12.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 2.8 | 8.4 | GO:0072180 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 2.7 | 8.1 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 2.7 | 8.0 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 2.6 | 7.9 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 2.5 | 7.5 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 2.4 | 12.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 2.4 | 7.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 2.3 | 7.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 2.3 | 16.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 2.3 | 11.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 2.3 | 6.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 2.2 | 6.6 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 2.2 | 13.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 2.2 | 2.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 2.2 | 8.7 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 2.1 | 15.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 2.1 | 2.1 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
| 2.1 | 48.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 2.1 | 20.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 2.1 | 6.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.9 | 5.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 1.9 | 5.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 1.9 | 20.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 1.9 | 7.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 1.8 | 9.1 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 1.8 | 5.3 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.8 | 7.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 1.8 | 19.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 1.8 | 10.6 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.7 | 10.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.7 | 5.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 1.7 | 27.6 | GO:0043248 | proteasome assembly(GO:0043248) |
| 1.7 | 5.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 1.7 | 6.8 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 1.7 | 5.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.7 | 1.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 1.6 | 29.3 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.6 | 1.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 1.6 | 14.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 1.6 | 3.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 1.6 | 3.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 1.6 | 4.9 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.6 | 8.1 | GO:0015671 | oxygen transport(GO:0015671) |
| 1.6 | 9.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 1.6 | 6.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 1.6 | 4.7 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 1.5 | 10.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 1.5 | 1.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 1.5 | 18.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 1.5 | 4.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.5 | 6.1 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 1.5 | 10.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 1.5 | 6.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 1.5 | 6.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 1.5 | 4.5 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.5 | 4.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 1.5 | 13.5 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 1.5 | 1.5 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 1.5 | 3.0 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 1.5 | 5.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 1.5 | 4.4 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 1.5 | 10.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 1.5 | 11.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.5 | 4.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 1.4 | 8.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.4 | 7.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.4 | 5.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 1.4 | 5.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.4 | 7.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 1.4 | 5.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.4 | 15.5 | GO:0060539 | diaphragm development(GO:0060539) |
| 1.4 | 9.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.4 | 4.2 | GO:1901355 | response to rapamycin(GO:1901355) |
| 1.4 | 1.4 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 1.4 | 14.9 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
| 1.4 | 4.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 1.3 | 4.0 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 1.3 | 4.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 1.3 | 4.0 | GO:0021546 | rhombomere development(GO:0021546) |
| 1.3 | 1.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.3 | 5.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 1.3 | 5.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.3 | 4.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.3 | 1.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 1.3 | 10.4 | GO:0097421 | liver regeneration(GO:0097421) |
| 1.3 | 3.9 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.3 | 5.2 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
| 1.3 | 3.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.3 | 5.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 1.3 | 2.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.3 | 6.4 | GO:0007144 | female meiosis I(GO:0007144) |
| 1.3 | 11.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 1.3 | 5.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.2 | 16.2 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 1.2 | 3.7 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 1.2 | 3.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 1.2 | 4.9 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 1.2 | 3.7 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.2 | 6.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.2 | 12.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 1.2 | 61.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 1.2 | 4.8 | GO:0018158 | protein oxidation(GO:0018158) |
| 1.2 | 2.4 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 1.2 | 11.9 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
| 1.2 | 1.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 1.2 | 11.8 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 1.2 | 1.2 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 1.2 | 4.7 | GO:0072235 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
| 1.2 | 2.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 1.2 | 3.5 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 1.2 | 9.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 1.2 | 5.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 1.1 | 14.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 1.1 | 3.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
| 1.1 | 2.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 1.1 | 48.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 1.1 | 3.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 1.1 | 6.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 1.1 | 14.5 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 1.1 | 5.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.1 | 3.3 | GO:0036166 | phenotypic switching(GO:0036166) |
| 1.1 | 5.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 1.1 | 6.6 | GO:0043144 | snoRNA processing(GO:0043144) |
| 1.1 | 4.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 1.1 | 5.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.1 | 2.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 1.1 | 6.4 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
| 1.1 | 6.4 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 1.1 | 2.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.1 | 4.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.0 | 10.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 1.0 | 3.1 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 1.0 | 6.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 1.0 | 7.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 1.0 | 5.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 1.0 | 3.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 1.0 | 3.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 1.0 | 1.0 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 1.0 | 4.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 1.0 | 1.0 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 1.0 | 3.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 1.0 | 3.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 1.0 | 3.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 1.0 | 6.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 1.0 | 2.0 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
| 1.0 | 3.0 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 1.0 | 3.0 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 1.0 | 2.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 1.0 | 4.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 1.0 | 3.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 1.0 | 6.0 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.0 | 6.9 | GO:0001907 | killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 1.0 | 7.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 1.0 | 3.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.0 | 3.0 | GO:0046032 | ADP catabolic process(GO:0046032) |
| 1.0 | 3.9 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 1.0 | 4.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 1.0 | 12.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 1.0 | 1.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 1.0 | 7.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 1.0 | 3.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.0 | 4.8 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 1.0 | 9.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 1.0 | 1.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.9 | 7.6 | GO:0031424 | keratinization(GO:0031424) |
| 0.9 | 1.9 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.9 | 6.6 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
| 0.9 | 6.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.9 | 2.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.9 | 2.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.9 | 12.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.9 | 2.8 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.9 | 3.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.9 | 3.7 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.9 | 6.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.9 | 1.8 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 0.9 | 8.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.9 | 2.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.9 | 2.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.9 | 4.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.9 | 0.9 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.9 | 3.6 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.9 | 7.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.9 | 1.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.9 | 3.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.9 | 3.5 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.9 | 3.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.9 | 2.7 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.9 | 4.4 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.9 | 7.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.9 | 7.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.9 | 1.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.9 | 4.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.9 | 14.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.9 | 3.5 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 0.9 | 9.6 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.9 | 0.9 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
| 0.9 | 21.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.9 | 16.4 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.9 | 0.9 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.9 | 0.9 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.9 | 50.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.9 | 2.6 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.9 | 5.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.9 | 5.1 | GO:0015669 | gas transport(GO:0015669) |
| 0.9 | 13.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.9 | 12.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.8 | 1.7 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.8 | 6.7 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.8 | 4.1 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.8 | 4.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.8 | 2.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.8 | 4.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.8 | 6.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.8 | 16.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.8 | 2.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.8 | 8.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.8 | 5.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.8 | 3.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.8 | 3.1 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.8 | 14.9 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.8 | 5.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.8 | 7.0 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.8 | 10.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.8 | 2.3 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.8 | 1.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.8 | 3.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.8 | 2.3 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 0.8 | 3.9 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.8 | 2.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.8 | 17.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.8 | 6.1 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.8 | 3.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.8 | 3.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.8 | 1.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.8 | 2.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.8 | 10.5 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.8 | 9.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.7 | 3.0 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
| 0.7 | 3.0 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.7 | 4.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.7 | 6.0 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.7 | 1.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.7 | 5.2 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.7 | 1.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.7 | 0.7 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.7 | 2.2 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.7 | 4.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.7 | 6.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.7 | 2.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.7 | 2.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.7 | 4.3 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.7 | 1.4 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.7 | 7.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.7 | 2.1 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.7 | 10.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.7 | 2.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.7 | 2.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.7 | 10.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.7 | 2.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.7 | 2.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.7 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
| 0.7 | 4.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.7 | 2.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.7 | 1.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.7 | 2.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 | 2.7 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.7 | 5.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 0.7 | 16.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.7 | 2.0 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.7 | 3.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.7 | 7.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.7 | 1.3 | GO:0021764 | amygdala development(GO:0021764) |
| 0.7 | 3.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.7 | 4.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.7 | 3.3 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) negative regulation of trophoblast cell migration(GO:1901164) |
| 0.7 | 17.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.6 | 5.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.6 | 1.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.6 | 7.7 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
| 0.6 | 1.9 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.6 | 1.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.6 | 3.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.6 | 1.9 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.6 | 3.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.6 | 3.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.6 | 1.3 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
| 0.6 | 1.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.6 | 2.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.6 | 3.1 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.6 | 2.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.6 | 21.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.6 | 1.2 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.6 | 3.1 | GO:0007320 | insemination(GO:0007320) |
| 0.6 | 2.5 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.6 | 4.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.6 | 1.8 | GO:0006273 | lagging strand elongation(GO:0006273) |
| 0.6 | 1.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 0.6 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.6 | 1.8 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.6 | 4.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.6 | 9.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.6 | 7.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.6 | 20.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.6 | 1.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.6 | 1.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.6 | 7.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.6 | 2.4 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.6 | 1.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.6 | 3.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.6 | 4.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.6 | 2.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.6 | 4.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.6 | 15.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.6 | 1.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
| 0.6 | 1.7 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.6 | 2.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.6 | 2.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.6 | 4.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.6 | 3.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.6 | 1.7 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.6 | 7.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.6 | 1.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.6 | 2.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.6 | 2.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.6 | 5.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.5 | 15.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.5 | 1.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.5 | 0.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.5 | 1.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.5 | 10.9 | GO:0007530 | sex determination(GO:0007530) |
| 0.5 | 1.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.5 | 1.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.5 | 1.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.5 | 1.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.5 | 0.5 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.5 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.5 | 3.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.5 | 2.7 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.5 | 0.5 | GO:1903750 | negative regulation of cellular respiration(GO:1901856) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.5 | 2.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.5 | 1.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.5 | 1.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 | 2.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.5 | 1.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.5 | 1.6 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.5 | 0.5 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.5 | 0.5 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.5 | 2.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.5 | 1.5 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.5 | 1.0 | GO:0000237 | leptotene(GO:0000237) |
| 0.5 | 7.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.5 | 1.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.5 | 2.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 2.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 | 5.5 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.5 | 5.0 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.5 | 2.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.5 | 1.5 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.5 | 1.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.5 | 2.0 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.5 | 1.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.5 | 1.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.5 | 1.5 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 | 2.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.5 | 1.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.5 | 0.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.5 | 1.9 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.5 | 1.0 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
| 0.5 | 4.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.5 | 3.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.5 | 1.9 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.5 | 4.3 | GO:0006560 | proline metabolic process(GO:0006560) |
| 0.5 | 6.7 | GO:0042407 | cristae formation(GO:0042407) |
| 0.5 | 1.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.5 | 1.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.5 | 1.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
| 0.5 | 0.9 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.5 | 0.9 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.5 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.5 | 3.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.5 | 2.8 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.5 | 12.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.5 | 4.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.5 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.5 | 2.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.5 | 4.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.5 | 2.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.5 | 0.9 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.5 | 1.8 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.5 | 1.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.4 | 2.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.4 | 3.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.4 | 4.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.4 | 1.3 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.4 | 2.2 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.4 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 | 8.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.4 | 1.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.4 | 1.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.4 | 4.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.4 | 1.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.4 | 1.3 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
| 0.4 | 2.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.4 | 2.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.4 | 2.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 | 0.4 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.4 | 2.2 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
| 0.4 | 7.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.4 | 6.5 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.4 | 3.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 | 0.9 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.4 | 1.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 | 1.7 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.4 | 0.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.4 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.4 | 1.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.4 | 2.1 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 | 1.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.4 | 1.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 | 1.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 2.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.4 | 4.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.4 | 8.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.4 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.4 | 3.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.4 | 1.2 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.4 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.4 | 2.4 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.4 | 2.4 | GO:0032796 | uropod organization(GO:0032796) |
| 0.4 | 1.2 | GO:1990859 | cellular response to endothelin(GO:1990859) |
| 0.4 | 7.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.4 | 5.6 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.4 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 | 30.1 | GO:0006413 | translational initiation(GO:0006413) |
| 0.4 | 2.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.4 | 1.2 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.4 | 2.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.4 | 4.7 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.4 | 1.2 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.4 | 0.8 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.4 | 3.9 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.4 | 1.2 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.4 | 1.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.4 | 1.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.4 | 9.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.4 | 3.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.4 | 2.6 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
| 0.4 | 1.5 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.4 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.4 | 0.7 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.4 | 1.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 | 1.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.4 | 1.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.4 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 | 1.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 | 1.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.4 | 12.5 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.4 | 1.5 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.4 | 2.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.4 | 5.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.4 | 1.8 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.4 | 1.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.4 | 1.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.4 | 1.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.4 | 2.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.4 | 2.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.4 | 2.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 | 2.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.4 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.3 | 1.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
| 0.3 | 1.4 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.3 | 1.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.3 | 1.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.3 | 1.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.3 | 1.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 | 1.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.3 | 1.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 | 1.0 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.3 | 6.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.3 | 1.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 | 1.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.3 | 2.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.3 | 1.0 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.3 | 0.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 1.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.3 | 1.0 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 | 0.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 | 2.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 | 4.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.3 | 1.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.3 | 3.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 | 1.9 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.3 | 2.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.3 | 0.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 | 0.9 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.3 | 0.9 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.3 | 1.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 0.9 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.3 | 0.6 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.3 | 1.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.3 | 0.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 | 0.6 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 | 2.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.3 | 0.3 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.3 | 2.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.3 | 0.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.3 | 1.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
| 0.3 | 3.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.3 | 1.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.3 | 6.3 | GO:0006414 | translational elongation(GO:0006414) |
| 0.3 | 0.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.3 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.3 | 3.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 | 0.9 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.3 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.3 | 0.9 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.3 | 2.7 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 2.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 | 2.1 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.3 | 0.9 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.3 | 0.9 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.3 | 2.6 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.3 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.3 | 0.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.3 | 0.6 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.3 | 0.3 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
| 0.3 | 8.6 | GO:0006401 | RNA catabolic process(GO:0006401) |
| 0.3 | 1.7 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.3 | 0.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.3 | 3.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.3 | 0.8 | GO:0019043 | establishment of viral latency(GO:0019043) |
| 0.3 | 2.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 | 2.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 | 1.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.3 | 2.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.3 | 0.5 | GO:0001798 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type I hypersensitivity(GO:0001812) type II hypersensitivity(GO:0002445) positive regulation of hypersensitivity(GO:0002885) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 | 3.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.3 | 1.6 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.3 | 0.8 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.3 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.3 | 1.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 2.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.3 | 1.6 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.3 | 2.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.3 | 1.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.3 | 2.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.3 | 4.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.3 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
| 0.3 | 1.0 | GO:0015786 | UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.3 | 2.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.3 | 0.8 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of receptor clustering(GO:1903911) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 1.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.3 | 0.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.3 | 1.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
| 0.3 | 1.3 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
| 0.3 | 1.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.3 | 2.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 | 2.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.3 | 4.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 | 2.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 | 2.3 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.2 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.2 | 1.7 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 0.7 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 | 2.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.2 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.2 | 7.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 | 21.9 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.2 | 1.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
| 0.2 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 1.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 | 4.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.2 | 0.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.2 | 0.2 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 | 0.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 | 2.3 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 0.2 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
| 0.2 | 0.9 | GO:0030656 | cobalamin transport(GO:0015889) regulation of vitamin metabolic process(GO:0030656) |
| 0.2 | 1.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 1.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.2 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 | 0.5 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.2 | 1.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.2 | 0.9 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.2 | 0.9 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 1.1 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.2 | 15.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.2 | 2.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 | 0.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 0.7 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.2 | 0.9 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.2 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 | 1.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 | 1.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 | 0.4 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 | 5.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 5.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.2 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.2 | 1.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.2 | 3.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.2 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 16.9 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
| 0.2 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.2 | 1.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.2 | 1.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 | 3.5 | GO:0000578 | embryonic axis specification(GO:0000578) |
| 0.2 | 4.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.2 | 0.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 0.4 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.2 | 5.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.2 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 | 0.6 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
| 0.2 | 1.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.2 | 0.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.2 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 1.0 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 | 1.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.2 | 4.9 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.2 | 3.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 0.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
| 0.2 | 2.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.2 | 2.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 2.3 | GO:0060416 | response to growth hormone(GO:0060416) |
| 0.2 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 | 0.6 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
| 0.2 | 0.7 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.2 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 | 3.2 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.2 | 2.6 | GO:0007140 | male meiosis(GO:0007140) |
| 0.2 | 1.3 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.2 | 0.5 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.2 | 0.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 | 2.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 2.8 | GO:0030903 | notochord development(GO:0030903) |
| 0.2 | 0.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.2 | 0.5 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.2 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.2 | 1.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.2 | 0.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 | 1.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.2 | 1.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.2 | 0.7 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 | 0.5 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.2 | 1.5 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
| 0.2 | 0.3 | GO:1902023 | L-arginine transport(GO:1902023) |
| 0.2 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 0.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.2 | 2.6 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.2 | 4.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 | 6.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.2 | 0.8 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.2 | 0.5 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 | 0.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.2 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.2 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.2 | 0.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 | 1.7 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.2 | 0.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.2 | 3.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 | 0.4 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 | 9.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.1 | 0.6 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.1 | 1.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 0.7 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 | 0.4 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.1 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 0.1 | 0.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 3.1 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.1 | 0.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 2.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 | 0.1 | GO:1902579 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
| 0.1 | 0.4 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.1 | 2.9 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 1.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 1.9 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 | 0.5 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 0.1 | 0.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.1 | 1.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.1 | 8.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.1 | 0.9 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.1 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 1.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 | 0.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.1 | 4.7 | GO:0051384 | response to glucocorticoid(GO:0051384) |
| 0.1 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 0.1 | 0.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 | 1.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 1.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 2.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.6 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 1.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.1 | 2.7 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 1.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.1 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.1 | 1.6 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.1 | 0.3 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.1 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 0.8 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
| 0.1 | 0.8 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 0.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 0.9 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
| 0.1 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.1 | 1.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 3.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.6 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.1 | 1.2 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.1 | 0.3 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.7 | GO:0033273 | response to vitamin(GO:0033273) |
| 0.1 | 1.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.1 | 4.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 0.4 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.1 | 0.3 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.1 | 1.4 | GO:0070265 | necrotic cell death(GO:0070265) |
| 0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 | 0.3 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 | 0.9 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 0.3 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 0.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 0.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.9 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
| 0.1 | 0.4 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 | 0.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 | 0.9 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.1 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 | 0.5 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 0.5 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 1.4 | GO:0050679 | positive regulation of epithelial cell proliferation(GO:0050679) |
| 0.1 | 0.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 0.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 1.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.1 | 0.3 | GO:0019395 | fatty acid oxidation(GO:0019395) |
| 0.1 | 0.4 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.1 | 0.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 1.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
| 0.1 | 0.3 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 2.4 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.1 | 0.1 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 1.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.1 | 1.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 0.6 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 1.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
| 0.1 | 0.7 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
| 0.1 | 1.0 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 | 1.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 1.3 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.1 | 0.3 | GO:0031034 | myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 1.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.2 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 | 10.1 | GO:0006412 | translation(GO:0006412) |
| 0.1 | 0.3 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
| 0.1 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.0 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 1.6 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 1.7 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
| 0.0 | 0.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.0 | 1.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.0 | 1.0 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.0 | 0.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
| 0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 1.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.0 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 | 0.3 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
| 0.0 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 | 0.4 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
| 0.0 | 0.8 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 | 0.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.0 | 0.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 0.0 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.1 | GO:1903008 | organelle disassembly(GO:1903008) |
| 0.0 | 0.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 0.0 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.0 | 0.1 | GO:0001562 | response to protozoan(GO:0001562) |
| 0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.0 | 0.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.0 | 0.1 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
| 0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
| 0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.0 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.0 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 0.2 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 | 0.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.0 | 0.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.0 | 0.8 | GO:0006399 | tRNA metabolic process(GO:0006399) |
| 0.0 | 0.8 | GO:0051607 | defense response to virus(GO:0051607) |
| 0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 | 0.1 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 | 0.1 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.4 | 32.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 3.8 | 7.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 3.3 | 3.3 | GO:0045298 | tubulin complex(GO:0045298) |
| 3.2 | 9.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 3.2 | 9.5 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
| 2.9 | 96.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 2.9 | 2.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 2.8 | 14.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 2.7 | 8.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 2.5 | 14.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 2.3 | 9.0 | GO:0032021 | NELF complex(GO:0032021) |
| 2.2 | 6.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 2.2 | 4.3 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 2.1 | 6.2 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 2.0 | 12.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 2.0 | 5.9 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 2.0 | 7.8 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 1.9 | 21.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 1.9 | 142.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 1.8 | 12.6 | GO:0097422 | tubular endosome(GO:0097422) |
| 1.8 | 93.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 1.8 | 5.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 1.7 | 5.2 | GO:1990047 | spindle matrix(GO:1990047) |
| 1.7 | 13.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 1.7 | 16.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 1.6 | 6.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 1.6 | 22.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 1.5 | 35.6 | GO:0005839 | proteasome core complex(GO:0005839) |
| 1.5 | 4.6 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
| 1.5 | 7.6 | GO:0034709 | methylosome(GO:0034709) |
| 1.5 | 4.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.5 | 10.6 | GO:0005638 | lamin filament(GO:0005638) |
| 1.4 | 86.8 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 1.4 | 17.4 | GO:0005687 | U4 snRNP(GO:0005687) |
| 1.4 | 11.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 1.4 | 18.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.4 | 66.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 1.3 | 4.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 1.3 | 8.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 1.3 | 6.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 1.3 | 10.6 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 1.3 | 3.9 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 1.3 | 40.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 1.3 | 7.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 1.3 | 14.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 1.3 | 19.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 1.3 | 48.6 | GO:0000786 | nucleosome(GO:0000786) |
| 1.3 | 5.0 | GO:0070552 | BRISC complex(GO:0070552) |
| 1.2 | 15.0 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 1.2 | 7.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 1.2 | 10.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.2 | 3.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 1.1 | 4.5 | GO:0060187 | cell pole(GO:0060187) |
| 1.1 | 10.0 | GO:0002177 | manchette(GO:0002177) |
| 1.1 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 1.1 | 3.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 1.1 | 8.7 | GO:0042382 | paraspeckles(GO:0042382) |
| 1.1 | 5.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.1 | 11.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.1 | 9.7 | GO:0061574 | ASAP complex(GO:0061574) |
| 1.1 | 3.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 1.0 | 4.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.0 | 4.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 1.0 | 2.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 1.0 | 4.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 1.0 | 2.9 | GO:0070069 | cytochrome complex(GO:0070069) |
| 1.0 | 3.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 1.0 | 6.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.0 | 5.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 1.0 | 3.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.9 | 3.8 | GO:0071942 | XPC complex(GO:0071942) |
| 0.9 | 2.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.9 | 9.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.9 | 2.8 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.9 | 3.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.9 | 2.7 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.9 | 2.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.9 | 3.6 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.9 | 2.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.9 | 2.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.9 | 5.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.8 | 5.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.8 | 19.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.8 | 13.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.8 | 8.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.8 | 7.9 | GO:0000796 | condensin complex(GO:0000796) |
| 0.8 | 8.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.8 | 3.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.8 | 5.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.8 | 7.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.8 | 2.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.8 | 3.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.8 | 5.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.8 | 2.3 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.8 | 1.5 | GO:0035101 | FACT complex(GO:0035101) |
| 0.7 | 3.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.7 | 7.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.7 | 5.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.7 | 6.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.7 | 2.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.7 | 4.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.7 | 3.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.7 | 6.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.7 | 3.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.7 | 0.7 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.7 | 2.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.7 | 8.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.7 | 3.4 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.7 | 10.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.7 | 3.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.7 | 6.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.7 | 0.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.7 | 4.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.7 | 2.0 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.7 | 7.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.7 | 6.0 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.7 | 0.7 | GO:0030677 | ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
| 0.7 | 0.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.7 | 3.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.7 | 1.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.6 | 2.6 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.6 | 3.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.6 | 3.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.6 | 4.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.6 | 8.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.6 | 2.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
| 0.6 | 1.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.6 | 4.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.6 | 2.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.6 | 3.5 | GO:0089701 | U2AF(GO:0089701) |
| 0.6 | 2.3 | GO:0008623 | CHRAC(GO:0008623) |
| 0.6 | 1.8 | GO:0000243 | commitment complex(GO:0000243) |
| 0.6 | 2.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.6 | 2.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.5 | 6.0 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.5 | 7.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.5 | 3.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.5 | 3.2 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.5 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.5 | 2.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.5 | 11.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.5 | 3.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.5 | 6.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.5 | 5.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.5 | 4.5 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.5 | 21.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.5 | 2.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.5 | 9.6 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.5 | 0.5 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
| 0.5 | 1.4 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 0.4 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.4 | 4.4 | GO:0030057 | desmosome(GO:0030057) |
| 0.4 | 10.4 | GO:0001741 | XY body(GO:0001741) |
| 0.4 | 6.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.4 | 2.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.4 | 3.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.4 | 2.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.4 | 4.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.4 | 10.0 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.4 | 4.1 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.4 | 1.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.4 | 6.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.4 | 11.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.4 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.4 | 14.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.4 | 2.3 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.4 | 2.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.4 | 1.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.4 | 5.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.4 | 3.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.4 | 7.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.4 | 0.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.4 | 16.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.4 | 4.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.4 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.4 | 6.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.4 | 31.2 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.3 | 1.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.3 | 4.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.3 | 5.9 | GO:0045120 | pronucleus(GO:0045120) |
| 0.3 | 16.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.3 | 1.4 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 1.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 3.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.3 | 1.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.3 | 4.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 19.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.3 | 2.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 1.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.3 | 3.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.3 | 4.2 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.3 | 2.6 | GO:0060091 | kinocilium(GO:0060091) |
| 0.3 | 1.0 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.3 | 4.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.3 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.3 | 3.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.3 | 9.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 1.9 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.3 | 3.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.3 | 2.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.3 | 1.2 | GO:0090537 | CERF complex(GO:0090537) |
| 0.3 | 1.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.3 | 3.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.3 | 2.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.3 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.3 | 1.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.3 | 2.5 | GO:0032982 | myosin filament(GO:0032982) |
| 0.3 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.3 | 1.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.3 | 24.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.3 | 3.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.3 | 19.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.3 | 1.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.3 | 1.6 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
| 0.3 | 2.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.3 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 1.1 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.3 | 3.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 0.8 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.3 | 1.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.3 | 2.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 1.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.3 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.3 | 8.5 | GO:0005840 | ribosome(GO:0005840) |
| 0.3 | 2.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.3 | 1.0 | GO:0071012 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
| 0.2 | 1.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 1.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 5.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.2 | 2.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 2.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.2 | 5.8 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.2 | 0.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 1.2 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 4.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.2 | 1.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.2 | 4.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.2 | 0.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.2 | 2.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.2 | 2.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 0.7 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
| 0.2 | 3.0 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 8.5 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 16.0 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.2 | 68.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.2 | 1.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
| 0.2 | 3.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 3.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.2 | 1.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 2.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 3.2 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.2 | 1.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.2 | 1.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 0.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 1.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
| 0.2 | 2.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 0.6 | GO:0005940 | septin ring(GO:0005940) |
| 0.2 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.2 | 1.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
| 0.2 | 2.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.2 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 1.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 2.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 1.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.2 | 1.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.2 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.2 | 2.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.2 | 2.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 1.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.2 | 4.7 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.2 | 1.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.2 | 1.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 8.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.1 | 2.3 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 5.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 1.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 0.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.1 | 1.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 1.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.6 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 6.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 1.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 3.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.8 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.1 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 3.0 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 5.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 6.9 | GO:0000776 | kinetochore(GO:0000776) |
| 0.1 | 0.3 | GO:0099631 | postsynaptic endocytic zone cytoplasmic component(GO:0099631) |
| 0.1 | 1.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.1 | 0.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 2.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 1.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 4.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 22.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.1 | 0.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
| 0.1 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.1 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 2.4 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.1 | 49.0 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.5 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.1 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 1.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 10.0 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 4.8 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 0.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.8 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 2.2 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.0 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 0.1 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 1.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 36.1 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.3 | GO:0030880 | RNA polymerase complex(GO:0030880) |
| 0.0 | 2.5 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 1.5 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.1 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.6 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.5 | GO:0005740 | mitochondrial envelope(GO:0005740) |
| 0.0 | 0.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 0.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 16.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 3.2 | 9.6 | GO:0035939 | microsatellite binding(GO:0035939) |
| 2.6 | 7.8 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 2.5 | 7.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 2.5 | 22.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 2.5 | 7.5 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 2.4 | 12.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 2.3 | 6.9 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 2.0 | 8.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 2.0 | 9.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.9 | 7.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 1.9 | 11.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 1.9 | 15.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 1.8 | 12.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 1.8 | 321.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 1.8 | 5.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 1.7 | 5.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 1.7 | 5.1 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
| 1.7 | 10.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.7 | 5.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 1.7 | 6.8 | GO:0042806 | fucose binding(GO:0042806) |
| 1.6 | 9.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 1.6 | 8.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 1.6 | 8.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 1.6 | 8.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 1.6 | 79.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 1.6 | 4.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 1.6 | 15.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 1.5 | 33.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 1.5 | 4.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 1.5 | 4.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 1.5 | 3.0 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
| 1.5 | 11.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 1.5 | 7.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 1.5 | 11.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 1.4 | 7.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 1.4 | 2.8 | GO:0030519 | snoRNP binding(GO:0030519) |
| 1.4 | 12.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 1.4 | 5.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 1.3 | 6.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.3 | 14.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.3 | 18.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 1.3 | 3.9 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 1.3 | 5.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 1.3 | 3.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 1.3 | 15.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 1.3 | 5.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 1.3 | 5.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.3 | 26.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 1.3 | 5.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 1.2 | 11.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 1.2 | 3.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 1.2 | 19.6 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.2 | 3.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 1.2 | 32.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 1.2 | 4.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 1.2 | 3.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 1.1 | 5.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.1 | 4.5 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 1.1 | 9.0 | GO:0031432 | titin binding(GO:0031432) |
| 1.1 | 4.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 1.1 | 6.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 1.1 | 3.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 1.1 | 31.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 1.1 | 3.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 1.1 | 5.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 1.1 | 4.4 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 1.1 | 5.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 1.1 | 11.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 1.1 | 4.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
| 1.1 | 7.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.0 | 5.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 1.0 | 3.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 1.0 | 6.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 1.0 | 7.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 1.0 | 1.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 1.0 | 3.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 1.0 | 8.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 1.0 | 4.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.0 | 4.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 1.0 | 8.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 1.0 | 4.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 1.0 | 6.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 1.0 | 3.0 | GO:0016015 | morphogen activity(GO:0016015) |
| 1.0 | 4.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 1.0 | 3.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 1.0 | 12.7 | GO:0070513 | death domain binding(GO:0070513) |
| 1.0 | 10.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 1.0 | 2.9 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 1.0 | 2.9 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
| 1.0 | 14.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 1.0 | 3.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 1.0 | 5.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
| 1.0 | 9.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 1.0 | 3.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 1.0 | 13.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.9 | 15.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.9 | 5.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.9 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.9 | 21.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.9 | 2.8 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
| 0.9 | 4.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.9 | 11.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.9 | 4.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.9 | 20.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.9 | 13.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.9 | 6.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.9 | 7.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.9 | 7.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.9 | 4.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.9 | 4.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.9 | 5.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.9 | 7.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.9 | 9.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.9 | 14.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.8 | 3.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.8 | 2.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.8 | 3.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.8 | 3.3 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.8 | 3.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.8 | 2.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.8 | 3.3 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
| 0.8 | 3.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.8 | 5.6 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.8 | 2.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.8 | 5.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.8 | 1.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
| 0.8 | 3.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.8 | 3.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.8 | 8.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.8 | 3.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.8 | 0.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.8 | 0.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.8 | 9.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.7 | 3.0 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.7 | 2.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.7 | 1.5 | GO:0001848 | complement binding(GO:0001848) |
| 0.7 | 3.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.7 | 2.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.7 | 7.9 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.7 | 11.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.7 | 2.8 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
| 0.7 | 4.9 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.7 | 4.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.7 | 8.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.7 | 2.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.7 | 2.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.7 | 2.0 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.7 | 2.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.7 | 9.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.7 | 0.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.7 | 2.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.7 | 2.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.6 | 1.9 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.6 | 1.9 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.6 | 3.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.6 | 7.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.6 | 7.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.6 | 3.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.6 | 5.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.6 | 36.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.6 | 5.5 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.6 | 3.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.6 | 4.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.6 | 3.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.6 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.6 | 20.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.6 | 1.8 | GO:0051379 | epinephrine binding(GO:0051379) |
| 0.6 | 1.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.6 | 3.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.6 | 4.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.6 | 3.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.6 | 2.3 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.6 | 6.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.6 | 4.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.6 | 26.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.6 | 4.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.6 | 23.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.6 | 1.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.6 | 13.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.6 | 2.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.6 | 8.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.6 | 2.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.6 | 2.8 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.6 | 6.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.6 | 2.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.6 | 2.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.6 | 3.4 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.6 | 2.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.6 | 2.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.5 | 9.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.5 | 1.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.5 | 1.6 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.5 | 1.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.5 | 2.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.5 | 4.2 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.5 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.5 | 4.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.5 | 1.6 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.5 | 1.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.5 | 2.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.5 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.5 | 5.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.5 | 1.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.5 | 2.0 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.5 | 2.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.5 | 9.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.5 | 1.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.5 | 1.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.5 | 1.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.5 | 5.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.5 | 4.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.5 | 2.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.5 | 9.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.5 | 1.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.5 | 8.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.5 | 2.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.5 | 6.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.5 | 5.1 | GO:0008430 | selenium binding(GO:0008430) |
| 0.5 | 1.4 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.5 | 1.4 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.5 | 10.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.5 | 3.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.5 | 5.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.5 | 2.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.5 | 1.8 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.4 | 1.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 3.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.4 | 2.7 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.4 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
| 0.4 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.4 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.4 | 0.9 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.4 | 1.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 12.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.4 | 4.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.4 | 2.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.4 | 2.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.4 | 0.8 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.4 | 7.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.4 | 3.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.4 | 5.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.4 | 0.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
| 0.4 | 7.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.4 | 3.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.4 | 1.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.4 | 1.6 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.4 | 2.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.4 | 2.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.4 | 1.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.4 | 1.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 4.0 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.4 | 0.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.4 | 5.1 | GO:0031386 | protein tag(GO:0031386) |
| 0.4 | 1.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.4 | 1.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.4 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.4 | 1.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.4 | 1.5 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.4 | 12.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.4 | 3.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.4 | 1.9 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.4 | 7.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.4 | 7.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.4 | 7.5 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.4 | 1.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.4 | 1.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.4 | 3.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.4 | 1.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.4 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.4 | 1.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.4 | 1.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 1.4 | GO:0019841 | retinol binding(GO:0019841) |
| 0.4 | 7.8 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.4 | 0.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.4 | 1.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.4 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.3 | 6.3 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.3 | 4.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.3 | 1.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.3 | 2.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.3 | 1.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.3 | 2.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.3 | 2.0 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.3 | 2.0 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 1.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.3 | 4.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.3 | 1.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.3 | 1.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.3 | 1.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.3 | 1.9 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.3 | 1.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.3 | 3.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.3 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.3 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.3 | 1.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.3 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.3 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.3 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.3 | 6.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.3 | 2.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.3 | 18.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.3 | 0.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.3 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.3 | 3.2 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.3 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.3 | 4.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.3 | 2.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 1.4 | GO:1990188 | euchromatin binding(GO:1990188) |
| 0.3 | 5.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.3 | 3.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.3 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.3 | 1.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 5.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.3 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.3 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.3 | 3.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.3 | 20.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.3 | 1.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 3.3 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.3 | 1.1 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.3 | 4.4 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.3 | 2.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.3 | 1.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.3 | 1.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 7.9 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.3 | 2.1 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.3 | 1.0 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.3 | 1.0 | GO:0033743 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.3 | 3.6 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.3 | 1.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.3 | 2.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.3 | 12.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.3 | 5.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.3 | 1.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.3 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.2 | 1.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.2 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.2 | 0.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.2 | 2.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.2 | 12.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.2 | 0.7 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 2.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.2 | 1.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 1.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.2 | 5.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
| 0.2 | 0.5 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.2 | 0.7 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.2 | 4.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 0.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 3.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 5.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 2.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.2 | 1.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.2 | 1.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.2 | 1.6 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
| 0.2 | 0.9 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.2 | 2.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 0.4 | GO:0043176 | amine binding(GO:0043176) |
| 0.2 | 6.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.2 | 14.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.2 | 0.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.2 | 0.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.2 | 2.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 1.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.2 | 2.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.2 | 2.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.2 | 0.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.2 | 3.3 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.2 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 1.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.2 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.2 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
| 0.2 | 0.4 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.2 | 5.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 0.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 3.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.2 | 2.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 1.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.2 | 1.3 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.2 | 12.2 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.2 | 0.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.2 | 3.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 1.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.2 | 0.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.2 | 3.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.2 | 1.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.2 | 2.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 5.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.2 | 3.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.2 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 5.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.2 | 5.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 1.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.2 | 4.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 5.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.2 | 0.7 | GO:0070891 | peptidoglycan binding(GO:0042834) lipoteichoic acid binding(GO:0070891) |
| 0.2 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 1.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.2 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 0.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.2 | 0.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 0.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.2 | 6.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 0.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.2 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 55.7 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
| 0.2 | 1.1 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 0.6 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 1.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 4.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.1 | 0.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.1 | 0.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 0.6 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.1 | 5.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 1.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.1 | 2.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 2.9 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 0.9 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.1 | 0.4 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 1.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 2.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.1 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 3.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 2.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 1.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.4 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 1.2 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 5.7 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 1.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 3.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 2.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.1 | 0.9 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 0.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
| 0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) wide pore channel activity(GO:0022829) |
| 0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.5 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 1.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.1 | 1.0 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 0.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 1.8 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
| 0.1 | 0.3 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.1 | 1.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.1 | 0.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.1 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
| 0.1 | 2.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 1.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.1 | 1.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 0.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.1 | 2.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 19.3 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.1 | 1.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 5.6 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.1 | 3.3 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 1.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.0 | 2.1 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.0 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 1.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.0 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 33.1 | GO:0003723 | RNA binding(GO:0003723) |
| 0.0 | 0.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
| 0.0 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 0.1 | GO:0070279 | vitamin B6 binding(GO:0070279) |
| 0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.6 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.5 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
| 0.0 | 0.6 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
| 0.0 | 0.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 1.7 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 1.5 | 72.5 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 1.2 | 34.5 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 1.1 | 14.9 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 1.0 | 45.3 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.9 | 33.1 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.9 | 14.7 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.9 | 46.7 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.7 | 19.9 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.6 | 21.2 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.6 | 5.4 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.6 | 23.3 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.5 | 1.6 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.5 | 8.9 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.5 | 11.4 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.5 | 36.8 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.5 | 18.0 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.5 | 43.4 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.5 | 13.0 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 13.1 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.5 | 17.2 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.5 | 5.1 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 3.1 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.4 | 15.7 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.4 | 6.5 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.4 | 13.6 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.4 | 0.4 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.4 | 4.1 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.4 | 1.1 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 15.5 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.4 | 13.0 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 5.6 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 4.6 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 7.1 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.3 | 2.8 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 10.1 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.3 | 4.9 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.3 | 16.7 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.3 | 9.2 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.3 | 7.8 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 8.5 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 5.1 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.3 | 13.9 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.2 | 3.0 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 1.4 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.2 | 13.5 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.2 | 2.1 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.2 | 5.9 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.2 | 10.5 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.2 | 6.7 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.2 | 1.8 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 1.9 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 8.5 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 4.3 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.2 | 5.7 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.2 | 7.1 | ST_FAS_SIGNALING_PATHWAY | Fas Signaling Pathway |
| 0.2 | 0.9 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 2.6 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 0.5 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.2 | 0.3 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 1.3 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 4.5 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 7.5 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.1 | 6.4 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.1 | 3.7 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.1 | 17.1 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.5 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 1.3 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 1.0 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.3 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 2.5 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.3 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.6 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 0.9 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.1 | 2.1 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.1 | 1.4 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.1 | 1.8 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 0.8 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 0.6 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 0.3 | ST_GA13_PATHWAY | G alpha 13 Pathway |
| 0.1 | 0.7 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.5 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.1 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 1.2 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.0 | 0.3 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.0 | 4.3 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 1.0 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.4 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
| 0.0 | 0.3 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.1 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.0 | 0.1 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.0 | 0.1 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.5 | 3.5 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 2.7 | 141.8 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 2.3 | 245.6 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 2.1 | 10.5 | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.8 | 32.5 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 1.7 | 1.7 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 1.7 | 3.4 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 1.7 | 3.3 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 1.6 | 88.1 | REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 1.6 | 15.8 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 1.4 | 97.9 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
| 1.3 | 14.4 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
| 1.3 | 27.3 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 1.2 | 14.7 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 1.2 | 12.0 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.2 | 4.7 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 1.1 | 12.4 | REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 1.1 | 15.5 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 1.0 | 8.1 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.0 | 26.1 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.0 | 7.0 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 1.0 | 24.7 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 1.0 | 33.0 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.9 | 14.1 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.9 | 15.6 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.9 | 11.0 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.8 | 17.4 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.8 | 22.7 | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.8 | 68.0 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.8 | 3.1 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.8 | 35.4 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.7 | 4.9 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.7 | 10.8 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.7 | 20.8 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.7 | 15.2 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.7 | 5.3 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.6 | 25.2 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.6 | 5.1 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.6 | 4.4 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.6 | 13.7 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.6 | 12.4 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.6 | 15.3 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.6 | 8.4 | REACTOME_MITOTIC_M_M_G1_PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.6 | 3.0 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.6 | 8.3 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.5 | 1.1 | REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.5 | 6.0 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.5 | 10.8 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.5 | 19.4 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.5 | 2.6 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.5 | 19.0 | REACTOME_SIGNALING_BY_NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.5 | 4.8 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.5 | 5.3 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.5 | 15.8 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.5 | 8.4 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.5 | 7.4 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.5 | 6.0 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.5 | 39.0 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
| 0.5 | 5.5 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.5 | 14.5 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.4 | 10.7 | REACTOME_TRNA_AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.4 | 6.6 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.4 | 29.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.4 | 3.0 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.4 | 5.8 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 3.3 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.4 | 6.8 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
| 0.4 | 20.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.4 | 3.0 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.4 | 30.0 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.4 | 8.7 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 9.4 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.4 | 3.2 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.4 | 11.4 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 0.4 | 9.1 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.3 | 1.0 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.3 | 2.7 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 3.3 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.3 | 8.2 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.3 | 8.9 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.3 | 11.9 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 8.1 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.3 | 4.4 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 3.4 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.3 | 0.9 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 1.5 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.3 | 9.9 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.3 | 9.2 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.3 | 2.2 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
| 0.3 | 3.1 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.3 | 3.1 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 4.1 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
| 0.2 | 6.5 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 2.1 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.2 | 6.3 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 3.2 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 7.2 | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.2 | 17.6 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.2 | 4.2 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.2 | 1.9 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
| 0.2 | 1.2 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 1.7 | REACTOME_GLOBAL_GENOMIC_NER_GG_NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.2 | 2.8 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 1.3 | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_ | Genes involved in Formation of RNA Pol II elongation complex |
| 0.2 | 1.3 | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | Genes involved in Signal transduction by L1 |
| 0.2 | 3.5 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 0.5 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 2.8 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.2 | 0.5 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 1.7 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 1.5 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.2 | 1.2 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.2 | 2.4 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.2 | 3.4 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 3.8 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
| 0.2 | 6.2 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 3.0 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 1.5 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 2.1 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 1.9 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.3 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 5.0 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 5.4 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.1 | 0.5 | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 1.1 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 8.8 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 1.5 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 6.6 | REACTOME_DIABETES_PATHWAYS | Genes involved in Diabetes pathways |
| 0.1 | 5.5 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 0.1 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 2.5 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.1 | 6.7 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 2.3 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.0 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 2.0 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.1 | 0.6 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 14.2 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 0.9 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 1.0 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 0.6 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 0.2 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 1.8 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 0.4 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 0.6 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.1 | 0.8 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 3.6 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.1 | 4.8 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 10.7 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 0.4 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.5 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 0.6 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.3 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 0.9 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 0.6 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 1.2 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.0 | 1.1 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.5 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.5 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 0.2 | REACTOME_GAB1_SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.0 | 0.5 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 1.6 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.3 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 0.0 | 0.5 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.0 | 0.3 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.7 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.2 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 0.1 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 0.3 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.7 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
|
|
|